Position in KURA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,090,655
-$856,337 QoQ
Shares Held
134,152
-28.4% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $408,627,656 across 136 Biotechnology names. KURA ranks #94 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in KURA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,090,655 | 134,152 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,946,992 | 187,391 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,002,014 | 113,222 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $606,484 | 105,110 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $865,246 | 131,098 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,268,297 | 145,614 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,792,540 | 91,737 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,565,205 | 124,585 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,639,346 | 311,268 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,175,320 | 151,274 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,117,727 | 232,207 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,090,957 | 197,633 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,357,795 | 274,554 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,069,462 | 327,918 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,850,945 | 281,914 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,746,372 | 95,274 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,911,814 | 181,083 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,925,580 | 208,970 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,195,380 | 117,212 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,425,855 | 116,348 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,192,870 | 112,942 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $731,518 | 22,398 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $876,457 | 28,605 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $203,652 | 12,494 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||